Table 3.
Median vedolizumab concentration, µg/mL [IQR] | |
---|---|
IBD [p = 0.003] | |
Remission [n = 30] | 14.2 [8.4–21.2] |
No remission [n = 53] | 8.5 [5.5–13.8] |
UC [p = 0.26] | |
Remission [n = 10] | 11.3 [8.8–21.2] |
No remission [n = 18] | 9.75 [5.5–13.8] |
CD [p = 0.008] | |
Remission [n = 20] | 15.0 [8.3–20.7] |
No remission [n = 35] | 7.5 [5.0–13.8] |
Abbreviations: IBD, inflammatory bowel disease; UC, ulcerative colitis; CD: Crohn’s disease; IQR, interquartile range.